Developer docs
API playgroundTry for free, no card

Search company profiles

UFP Technologies

Full company profile

uuid000abpd

Namestring
UFP Technologies
Legal namestring
UFP Technologies, Inc.
Websiteurl
ufpt.com
Company typeenum
Public
Founded yearint
1963
Descriptiontext

UFP Technologies, Inc. is a publicly traded (NASDAQ: UFPT) contract development and manufacturing organization (CDMO) founded in 1963 and headquartered in Newburyport, Massachusetts. The company designs, engineers, and manufactures single-use and single-patient medical devices, sterile packaging, and highly engineered custom components for medical device OEMs and industrial customers. It operates two reportable segments: UFP MedTech, which serves robotic surgery, patient surfaces and support, interventional/surgical, infection control, wound care, and wearables end markets; and Advanced Components, which supplies aerospace, defense, automotive, and industrial customers with acoustic/thermal insulation, fluid and air management, comfort/support, and trim/structural components.

The company's technology base spans precision foam fabrication (reticulated polyurethane, cross-linked polyethylene), thin film thermoforming for implantable devices, thermoplastic injection molding, compression molding, and cleanroom manufacturing across ISO 13485- and FDA-registered facilities. Proprietary capabilities include the patent-pending FirmaLite composite load floors, thin film thermoforming (Welch Fluorocarbon), and 72-hour rapid prototyping. Revenue is generated primarily through project-based, multi-year CDMO engagements with medical device OEMs, priced per quote based on volume, complexity, and specifications. Distribution is direct to enterprise OEMs with no channel intermediaries, supported by industry trade shows (MD&M West, Interphex, Foam Expo) and investor relations activity.

Financially, UFP generated $602.8M in revenue in 2025 (+19.5% YoY), with medical sales of $555.3M (92% of total) and Advanced Components at $47.5M. The company has nearly tripled revenue since 2021, driven by an aggressive acquisition cadence of 15+ deals, most recently Welch Fluorocarbon, AJR Enterprises, AQF Medical, UNIPEC, and TPI. Adjusted operating margin reached 16.7% in Q1 2026 with a 28.8% gross margin. Global operations span 20+ facilities in the U.S., Puerto Rico, Dominican Republic, Costa Rica, Ireland, Mexico, and Singapore, with the Intuitive Surgical robotic-surgery supply agreement extended through 2029. A planned CEO transition from R. Jeffrey Bailly to Mitchell Rock became effective June 4, 2026.

Short descriptiontext

UFP Technologies is a publicly traded CDMO that designs and manufactures single-use medical devices, sterile packaging, and engineered custom components for medical device OEMs and aerospace, defense, and automotive customers, operating across more than 20 facilities in the U.S., Puerto Rico, Latin America, Ireland, Mexico, and Singapore.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNewburyport, United States
HQ citystring
Newburyport
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices23 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device manufacturing, sterile packaging solutions, contract development manufacturing, engineered foam components, thermoformed medical packaging
Industry1 code
PRIMARYIMAGAGAB
Industrial Electronics Original Design Manufacturing (ODM)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Industrial Electronics Manufacturing Services (EMS/ODM for industrial electronics)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing33911
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Special Industry Machinery, Nec3559
Product category
Medical Device Contract Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Manufacturing Services
TypeProfessional Services
Description

UFP Technologies generates the majority of its revenue as a CDMO specializing in single-use and single-patient medical devices and sterile packaging. Revenue comes from design, development, and manufacturing services for medical device OEMs across segments including robotic surgery, patient surfaces, infection control, interventional/surgical, wound care, and wearables. The company operates on a project-based model with long-term customer relationships and contracts.

ufpt.com
2Advanced Components Manufacturing
TypeOne Time License
Description

Custom engineered components and packaging for aerospace, defense, automotive, and industrial applications. Includes acoustic and thermal insulation, fluid management, comfort/support/protection, trim and structural components, and protective packaging solutions.

ufpt.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom manufacturing services - pricing determined per project
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available; services are quoted based on customer specifications, volume requirements, and project complexity

ufpt.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

UFP Technologies is a contract development and manufacturing organisation that designs, engineers, and produces single-use and single-patient medical devices, sterile barrier packaging, and custom-engineered components made from foams, plastics, films, and moulded fibre. The company operates two segments — UFP MedTech and Advanced Components — serving medical device OEMs as well as aerospace, defence, automotive, and industrial customers with engineered product solutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Revenue grew 19.5% to $602.8 million in 2025, with medical sales up 23.2%
+3 more records
Product overview1 text field

UFP Technologies operates as a contract development and manufacturing organization (CDMO) offering two primary business segments: UFP MedTech and Advanced Components. UFP MedTech provides single-use and single-patient medical device development and manufacturing services including design expertise, skilled engineering, material selection, rapid prototyping, full-scale production, and nearshore manufacturing. The MedTech segment serves interventional and surgical procedures, infection control, patient surfaces and support, diagnostics, therapeutics, wearables, and wound care markets. Advanced Components provides custom engineered components and packaging for aerospace, defense, automotive, and industrial applications, including protective cases, acoustic and thermal insulation, fluid and air management solutions, comfort and protection products, and trim and structural components. The company uses various materials including foams, films, plastics, nonwovens, fabrics, and composites, with manufacturing capabilities in compression molding, thermoplastic welding, vacuum forming, thin film thermoforming, injection molding, die cutting, CNC routing, water jet cutting, and lamination.

Product and service1 record
1Single-use and single-patient medical devices
Scale indicator24 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Manufacturing supply agreement for robotic surgery draping systems and components, extended and expanded through December 31, 2029 with increased minimum volumes. This is a major strategic partnership providing multi-year revenue visibility for the company's robotic surgery business.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-17
Description

Acquisition of UNIPEC headquartered in Rockville, MD - manufacturer of precision thermoformed and heat-sealed polymer components for shielding batteries in Class III implantable medical devices. Complements Welch Fluorocarbon operation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-17
Description

Acquisition of TPI based in Anasco, Puerto Rico - specialty manufacturer of precision thermoplastic injection-molded components for medical devices. Strategically located near DAS business in Dominican Republic.

4AJR Specialty Products
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-01
Description

Acquisition of AJR Specialty Products of St. Charles, IL - sister company expanding cut and sew capabilities for patient surfaces and transfer devices.

prnewswire.com
5AJR Custom Foam Products
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-01
Description

Acquisition of AJR Custom Foam Products of St. Charles, IL - sister company expanding foam fabrication capabilities for patient handling products.

prnewswire.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-26
Description

Acquisition of Ireland and Singapore-based developer and manufacturer of foam and thermoplastic components for medical devices and packaging. Expands European and Asian manufacturing presence with operations in Navan, Ireland and Singapore.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

Acquisition of Marble Medical in Tallahassee, FL - manufacturer of adhesive-based medical components and single-use devices.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-16
Description

Acquisition of Welch Fluorocarbon in Dover, NH - manufacturer of thermoformed implantable medical device components utilizing thin high-performance films. Enhances thin film thermoforming capabilities for demanding implantable applications.

9AJR Enterprises
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-07-01
Description

Acquisition of AJR Enterprises of St. Charles, IL with manufacturing in Dominican Republic - developer and manufacturer of single-use safe patient handling systems. Generated approximately $70 million in sales in 2023.

ufpt.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Acquisition of Advant Medical located in Galway, Ireland with operations in Costa Rica and partner manufacturing in Mexico - manufacturer of Class I, II, and III medical devices and packaging.

11DAS Medical
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Acquisition of DAS Medical in Atlanta, GA with manufacturing in Dominican Republic - medical device contract manufacturer specializing in single-use surgical equipment covers, robotic draping systems and fluid control pouches.

ufpt.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Acquisition of Contech Medical in Providence, RI with partner manufacturing in Costa Rica - global leader in development and manufacture of Class III medical device packaging for catheters and guidewires.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

Acquisition of Dielectrics in Chicopee, MA - medical device manufacturer using thermoplastic materials and innovator of the Reebok Pump.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Integer Holdings is a publicly traded medical device contract development and manufacturing organization (CDMO) specializing in active implantable devices, interventional, and portable medical products. It is the most direct large-cap medical CDMO peer to UFP Technologies, competing for similar OEM customers with overlapping capabilities in design, prototyping, and manufacturing.

TypeDirect peer
Description

SteriPack Group is a private contract manufacturer and packager specializing in sterile barrier packaging, medical device assembly, and kitting services. It is a closely comparable peer to UFP's Contech Medical and packaging-focused operations, serving medical OEMs with regulatory-compliant sterile packaging solutions.

TypeDirect peer
Description

Heraeus Medical Components, part of the Heraeus Group, is a contract manufacturer of components and subassemblies for active implantable medical devices, including leads, cables, and sensors. It competes with UFP's Welch Fluorocarbon and UNIPEC operations in thin film thermoforming and precision polymer components for Class III implantable devices.

4Biomerics
TypeDirect peer
Description

Biomerics is a private medical device contract manufacturer offering design, engineering, and manufacturing services across interventional, structural heart, and other implantable applications. It is a focused mid-market CDMO peer with comparable capabilities in polymer processing and single-use device manufacturing for medical OEMs.

5Nipro Corporation
TypeBroad incumbent
Description

Nipro Corporation is a Japanese global medical device manufacturer with manufacturing operations including renal, interventional, and injection-molded medical components. It competes with UFP in select medical device manufacturing categories and offers comparable contract manufacturing services for OEMs seeking diversified geographic supply.

TypeBroad incumbent
Description

Flex Ltd is a global contract manufacturing giant with a Health Solutions business serving medical device, diagnostics, and pharmaceutical customers. While much larger and more diversified than UFP, Flex Health Solutions competes for the same medical OEM outsourcing programs that UFP targets, particularly in single-use devices and consumables.

TypeDirect peer
Description

Resonetics is a private medical device contract manufacturer specializing in laser micromachining, nitinol processing, and thin-wall tubing for interventional and implantable devices. It is a closely comparable private peer with a similar focus on high-precision components and CDMO services for the same OEM customer base that UFP serves in its implantable device segment.

TypeDirect peer
Description

Confluent Medical Technologies is a private medical device CDMO specializing in nitinol components, balloon catheters, and bioelectronic materials for medical device OEMs. It competes with UFP for OEM outsourcing relationships in implantable and interventional device manufacturing, with overlapping materials expertise and cleanroom manufacturing capabilities.

9Nordson Corporation (Medical Segment)
TypeBroad incumbent
Description

Nordson Corporation is a diversified precision technology company with a Medical segment offering fluid management, drug delivery, and medical component manufacturing solutions. While broader than UFP, Nordson's Medical segment (which includes the former Vention Medical assets) competes directly with UFP's single-use device and component manufacturing business for OEM customers.

TypeBroad incumbent
Description

Jabil Inc. is a global contract manufacturer with a Healthcare segment serving medical device, pharmaceutical, and consumer health customers with design, manufacturing, and supply chain services. It competes with UFP in medical device manufacturing services at the larger end of the market, leveraging global scale and broader capabilities than UFP's specialized niche.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A15 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UFP Technologies

Medical Device Contract Manufacturingufpt.com

UFP Technologies is a publicly traded CDMO that designs and manufactures single-use medical devices, sterile packaging, and engineered custom components for medical device OEMs and aerospace, defense, and automotive customers, operating across more than 20 facilities in the U.S., Puerto Rico, Latin America, Ireland, Mexico, and Singapore.

What UFP Technologies does

UFP Technologies, Inc. is a publicly traded (NASDAQ: UFPT) contract development and manufacturing organization (CDMO) founded in 1963 and headquartered in Newburyport, Massachusetts. The company designs, engineers, and manufactures single-use and single-patient medical devices, sterile packaging, and highly engineered custom components for medical device OEMs and industrial customers. It operates two reportable segments: UFP MedTech, which serves robotic surgery, patient surfaces and support, interventional/surgical, infection control, wound care, and wearables end markets; and Advanced Components, which supplies aerospace, defense, automotive, and industrial customers with acoustic/thermal insulation, fluid and air management, comfort/support, and trim/structural components.

The company's technology base spans precision foam fabrication (reticulated polyurethane, cross-linked polyethylene), thin film thermoforming for implantable devices, thermoplastic injection molding, compression molding, and cleanroom manufacturing across ISO 13485- and FDA-registered facilities. Proprietary capabilities include the patent-pending FirmaLite composite load floors, thin film thermoforming (Welch Fluorocarbon), and 72-hour rapid prototyping. Revenue is generated primarily through project-based, multi-year CDMO engagements with medical device OEMs, priced per quote based on volume, complexity, and specifications. Distribution is direct to enterprise OEMs with no channel intermediaries, supported by industry trade shows (MD&M West, Interphex, Foam Expo) and investor relations activity.

Financially, UFP generated $602.8M in revenue in 2025 (+19.5% YoY), with medical sales of $555.3M (92% of total) and Advanced Components at $47.5M. The company has nearly tripled revenue since 2021, driven by an aggressive acquisition cadence of 15+ deals, most recently Welch Fluorocarbon, AJR Enterprises, AQF Medical, UNIPEC, and TPI. Adjusted operating margin reached 16.7% in Q1 2026 with a 28.8% gross margin. Global operations span 20+ facilities in the U.S., Puerto Rico, Dominican Republic, Costa Rica, Ireland, Mexico, and Singapore, with the Intuitive Surgical robotic-surgery supply agreement extended through 2029. A planned CEO transition from R. Jeffrey Bailly to Mitchell Rock became effective June 4, 2026.

UFP Technologies firmographics

Firmographics
Name
UFP Technologies
Legal name
UFP Technologies, Inc.
Website
https://ufpt.com
Company type
Public
Founded year
1963
Operating status
Operating
Headcount range
501–1,000 employees
Short description
UFP Technologies is a publicly traded CDMO that designs and manufactures single-use medical devices, sterile packaging, and engineered custom components for medical device OEMs and aerospace, defense, and automotive customers, operating across more than 20 facilities in the U.S., Puerto Rico, Latin America, Ireland, Mexico, and Singapore.
Ownership category
akta.pro rank

UFP Technologies industry classification

Industry
Product category
Medical Device Contract Manufacturing
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (33911)
SIC
Surgical & Medical Instruments & Apparatus (3841), Special Industry Machinery, Nec (3559)
akta.pro industry
PRIMARYIMAGAGAB
Industrial Electronics Original Design Manufacturing (ODM)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Industrial Electronics Manufacturing Services (EMS/ODM for industrial electronics)

Keywords

  • Medical device manufacturing
  • Sterile packaging solutions
  • Contract development manufacturing
  • Engineered foam components
  • Thermoformed medical packaging

Where UFP Technologies is headquartered

Location

Headquarters

HQ city
Newburyport
HQ country
United States
HQ region
North America

Offices23 records

Markets served

UFP Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Device Manufacturing Services: UFP Technologies generates the majority of its revenue as a CDMO specializing in single-use and single-patient medical devices and sterile packaging. Revenue comes from design, development, and manufacturing services for medical device OEMs across segments including robotic surgery, patient surfaces, infection control, interventional/surgical, wound care, and wearables. The company operates on a project-based model with long-term customer relationships and contracts.
  2. Advanced Components Manufacturing: Custom engineered components and packaging for aerospace, defense, automotive, and industrial applications. Includes acoustic and thermal insulation, fluid management, comfort/support/protection, trim and structural components, and protective packaging solutions.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom manufacturing services - pricing determined per project

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

UFP Technologies product offering

Product offering

Core offering

UFP Technologies is a contract development and manufacturing organisation that designs, engineers, and produces single-use and single-patient medical devices, sterile barrier packaging, and custom-engineered components made from foams, plastics, films, and moulded fibre. The company operates two segments — UFP MedTech and Advanced Components — serving medical device OEMs as well as aerospace, defence, automotive, and industrial customers with engineered product solutions.

Product overview

UFP Technologies operates as a contract development and manufacturing organization (CDMO) offering two primary business segments: UFP MedTech and Advanced Components. UFP MedTech provides single-use and single-patient medical device development and manufacturing services including design expertise, skilled engineering, material selection, rapid prototyping, full-scale production, and nearshore manufacturing. The MedTech segment serves interventional and surgical procedures, infection control, patient surfaces and support, diagnostics, therapeutics, wearables, and wound care markets. Advanced Components provides custom engineered components and packaging for aerospace, defense, automotive, and industrial applications, including protective cases, acoustic and thermal insulation, fluid and air management solutions, comfort and protection products, and trim and structural components. The company uses various materials including foams, films, plastics, nonwovens, fabrics, and composites, with manufacturing capabilities in compression molding, thermoplastic welding, vacuum forming, thin film thermoforming, injection molding, die cutting, CNC routing, water jet cutting, and lamination.

Differentiator

Problem solved

Functional benefit

Products and services

  • Single-use and single-patient medical devices

Quantifiable outcome

  • Revenue grew 19.5% to $602.8 million in 2025, with medical sales up 23.2%
  • +3 more outcomes

Companies that use UFP Technologies

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles2 records

UFP Technologies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

UFP Technologies partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core.

  • Intuitive SurgicalcoreStrategic or Co-development Partner · 1 February 2026Manufacturing supply agreement for robotic surgery draping systems and components, extended and expanded through December 31, 2029 with increased minimum volumes. This is a major strategic partnership providing multi-year revenue visibility for the company's robotic surgery business.
  • UNIPEC (Universal Plastics & Engineering Company)coreStrategic or Co-development Partner · 17 July 2025Acquisition of UNIPEC headquartered in Rockville, MD - manufacturer of precision thermoformed and heat-sealed polymer components for shielding batteries in Class III implantable medical devices. Complements Welch Fluorocarbon operation.
  • TPI (Techno Plastics Industries)coreStrategic or Co-development Partner · 17 July 2025Acquisition of TPI based in Anasco, Puerto Rico - specialty manufacturer of precision thermoplastic injection-molded components for medical devices. Strategically located near DAS business in Dominican Republic.
  • AJR Specialty ProductscoreStrategic or Co-development Partner · 1 July 2025Acquisition of AJR Specialty Products of St. Charles, IL - sister company expanding cut and sew capabilities for patient surfaces and transfer devices.
  • AJR Custom Foam ProductscoreStrategic or Co-development Partner · 1 July 2025Acquisition of AJR Custom Foam Products of St. Charles, IL - sister company expanding foam fabrication capabilities for patient handling products.
  • AQF Medical (AQF Limited)coreStrategic or Co-development Partner · 26 August 2024Acquisition of Ireland and Singapore-based developer and manufacturer of foam and thermoplastic components for medical devices and packaging. Expands European and Asian manufacturing presence with operations in Navan, Ireland and Singapore.
  • Marble MedicalcoreStrategic or Co-development Partner · 1 August 2024Acquisition of Marble Medical in Tallahassee, FL - manufacturer of adhesive-based medical components and single-use devices.
  • Welch FluorocarboncoreStrategic or Co-development Partner · 16 July 2024Acquisition of Welch Fluorocarbon in Dover, NH - manufacturer of thermoformed implantable medical device components utilizing thin high-performance films. Enhances thin film thermoforming capabilities for demanding implantable applications.
  • AJR EnterprisescoreStrategic or Co-development Partner · 1 July 2024Acquisition of AJR Enterprises of St. Charles, IL with manufacturing in Dominican Republic - developer and manufacturer of single-use safe patient handling systems. Generated approximately $70 million in sales in 2023.
  • Advant MedicalcoreStrategic or Co-development Partner · 1 January 2022Acquisition of Advant Medical located in Galway, Ireland with operations in Costa Rica and partner manufacturing in Mexico - manufacturer of Class I, II, and III medical devices and packaging.
  • DAS MedicalcoreStrategic or Co-development Partner · 1 January 2021Acquisition of DAS Medical in Atlanta, GA with manufacturing in Dominican Republic - medical device contract manufacturer specializing in single-use surgical equipment covers, robotic draping systems and fluid control pouches.
  • Contech MedicalcoreStrategic or Co-development Partner · 1 January 2021Acquisition of Contech Medical in Providence, RI with partner manufacturing in Costa Rica - global leader in development and manufacture of Class III medical device packaging for catheters and guidewires.
  • DielectricscoreStrategic or Co-development Partner · 1 January 2018Acquisition of Dielectrics in Chicopee, MA - medical device manufacturer using thermoplastic materials and innovator of the Reebok Pump.

Scale indicators24 records

Recent moves8 records

Expansion highlights6 records

UFP Technologies competitors and assessment

Company assessment

Direct peers

  • Integer Holdings Corporation: Integer Holdings is a publicly traded medical device contract development and manufacturing organization (CDMO) specializing in active implantable devices, interventional, and portable medical products. It is the most direct large-cap medical CDMO peer to UFP Technologies, competing for similar OEM customers with overlapping capabilities in design, prototyping, and manufacturing.
  • SteriPack Group: SteriPack Group is a private contract manufacturer and packager specializing in sterile barrier packaging, medical device assembly, and kitting services. It is a closely comparable peer to UFP's Contech Medical and packaging-focused operations, serving medical OEMs with regulatory-compliant sterile packaging solutions.
  • Heraeus Medical Components: Heraeus Medical Components, part of the Heraeus Group, is a contract manufacturer of components and subassemblies for active implantable medical devices, including leads, cables, and sensors. It competes with UFP's Welch Fluorocarbon and UNIPEC operations in thin film thermoforming and precision polymer components for Class III implantable devices.
  • Biomerics: Biomerics is a private medical device contract manufacturer offering design, engineering, and manufacturing services across interventional, structural heart, and other implantable applications. It is a focused mid-market CDMO peer with comparable capabilities in polymer processing and single-use device manufacturing for medical OEMs.
  • Resonetics: Resonetics is a private medical device contract manufacturer specializing in laser micromachining, nitinol processing, and thin-wall tubing for interventional and implantable devices. It is a closely comparable private peer with a similar focus on high-precision components and CDMO services for the same OEM customer base that UFP serves in its implantable device segment.
  • Confluent Medical Technologies: Confluent Medical Technologies is a private medical device CDMO specializing in nitinol components, balloon catheters, and bioelectronic materials for medical device OEMs. It competes with UFP for OEM outsourcing relationships in implantable and interventional device manufacturing, with overlapping materials expertise and cleanroom manufacturing capabilities.

Broad incumbents

  • Nipro Corporation: Nipro Corporation is a Japanese global medical device manufacturer with manufacturing operations including renal, interventional, and injection-molded medical components. It competes with UFP in select medical device manufacturing categories and offers comparable contract manufacturing services for OEMs seeking diversified geographic supply.
  • Flex Ltd (Health Solutions): Flex Ltd is a global contract manufacturing giant with a Health Solutions business serving medical device, diagnostics, and pharmaceutical customers. While much larger and more diversified than UFP, Flex Health Solutions competes for the same medical OEM outsourcing programs that UFP targets, particularly in single-use devices and consumables.
  • Nordson Corporation (Medical Segment): Nordson Corporation is a diversified precision technology company with a Medical segment offering fluid management, drug delivery, and medical component manufacturing solutions. While broader than UFP, Nordson's Medical segment (which includes the former Vention Medical assets) competes directly with UFP's single-use device and component manufacturing business for OEM customers.
  • Jabil Inc. (Healthcare): Jabil Inc. is a global contract manufacturer with a Healthcare segment serving medical device, pharmaceutical, and consumer health customers with design, manufacturing, and supply chain services. It competes with UFP in medical device manufacturing services at the larger end of the market, leveraging global scale and broader capabilities than UFP's specialized niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

UFP Technologies social profiles

Digital presence

UFP Technologies compliance and trust

Trust signal

Compliance6 records

UFP Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UFP Technologies leadership team

Management profile

Number of profiles

UFP Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

UFP Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UFP Technologies M&A and investment

M&A and investment

M&A15 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UFP Technologies

What does UFP Technologies do?

UFP Technologies is a contract development and manufacturing organisation that designs, engineers, and produces single-use and single-patient medical devices, sterile barrier packaging, and custom-engineered components made from foams, plastics, films, and moulded fibre. The company operates two segments — UFP MedTech and Advanced Components — serving medical device OEMs as well as aerospace, defence, automotive, and industrial customers with engineered product solutions.

Is UFP Technologies a public or private company?

UFP Technologies is a public company. It is classified as public and is currently operating.

When was UFP Technologies founded?

UFP Technologies was founded in 1963. It employs 501 to 1,000 people.

Where is UFP Technologies based?

UFP Technologies is headquartered in Newburyport, United States, in the North America region.

How does UFP Technologies make money?

Two revenue lines are on record. Medical Device Manufacturing Services are the primary driver. The others are advanced Components Manufacturing.

Who are UFP Technologies's main competitors?

Direct peers on record are Integer Holdings Corporation, SteriPack Group, Heraeus Medical Components, Biomerics, Resonetics and Confluent Medical Technologies. Broad incumbents are Nipro Corporation, Flex Ltd (Health Solutions), Nordson Corporation (Medical Segment) and Jabil Inc. (Healthcare).

Does UFP Technologies have an API?

No public API is recorded for UFP Technologies.

What industry is UFP Technologies in?

UFP Technologies's product category is Medical Device Contract Manufacturing. Its primary akta.pro industry code is IMAGAGAB, Industrial Electronics Original Design Manufacturing (ODM). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsUFP Technologies, Inc. $UFPT Stock: Allspring Global Investments Holdings LLC Trims PositionAllspring Global Investments Holdings LLC cut its UFP Technologies stake by 29.9% in Q3, selling 58,521 shares. BlackRock, Dimensional, and others also adjusted positions, while analysts hold a neutral average rating. The company reported Q3 EPS of $2.88, beating estimates.American Banking and Market NewsUFP Technologies, Inc. $UFPT Stock Sold by Boston Trust Walden CorpBoston Trust Walden Corp reduced its UFP Technologies stake by 4.7% in Q3, selling 15,939 shares. UFP reported Q3 adjusted EPS of $2.88 and revenue of $172.4 million, beating estimates. Analysts have an average "Hold" rating on the stock.YahooUFP Technologies: 3 Key Takeaways for Long-Term InvestorsUFP Technologies reported Q3 2026 sales of $172.4 million, up 11.6% year-over-year, with organic growth of 11.1%. Medical technology sales rose 12.5%, and production transfers to the Dominican Republic face delays, affecting gross margins. The company's leverage ratio remains under 1x, supporting larger acquisition targets.The Motley FoolUFP Technologies: 3 Key Takeaways for Long-Term InvestorsUFP Technologies reported Q3 2026 sales of $172.4 million, up 11.6% year-over-year, with organic growth of 11.1%. Medical technology sales rose 12.5%, and management is shifting labor-intensive production to the Dominican Republic, which may delay gross margin improvement. The company's leverage ratio is under 1x, supporting larger acquisition targets.FinancialContent Business PageUFPT Q3 2026 deep dive: broad-based MedTech growth and acquisition strategy drive resultsUFP Technologies reported Q3 2026 revenue of $172.4 million, up 11.6% year-on-year, and adjusted EPS of $2.88, beating analyst estimates. MedTech sales grew 12.5% organically, and the company acquired CI Medical to expand plastics capabilities. Management expects DAS Medical capacity expansion and AJR offshore transfer completion by 2027 to drive further growth.ChartmillUFP Technologies (NASDAQ:UFPT) Posts Inline Q3 Revenue and Clear EPS Beat Amid Cautious TradingUFP Technologies reported Q3 2026 revenue of $172.4 million, about 1.3% above consensus, and adjusted EPS of $2.88, roughly 5.2% above estimates. Net income rose 25.8% year over year, but after-hours trading was flat, reflecting cautious investor sentiment. Management did not provide Q4 or full-year guidance.The future of tradingUFP Technologies Inc reports results for the quarter ended September 30 - Earnings SummaryUFP Technologies reported quarterly adjusted EPS of $2.88 for the quarter ended September 30, beating the $2.69 analyst mean. Revenue rose 11.6% to $172.43 million, and the company beat all four quarters of the year. Analysts maintain a buy rating with a $355 price target.FinancialContent Business PageUFP Technologies (NASDAQ:UFPT) delivers impressive Q3 2026UFP Technologies reported Q3 2026 revenue of $172.4 million, up 11.6% year-on-year, beating analyst estimates by 3.2%. Adjusted EPS of $2.88 exceeded consensus by 7.3%, and adjusted operating margin held at 16%. Analysts project 5.6% revenue growth over the next 12 months.FinancialContent Business PageUFP Technologies (UFPT) Q3 earnings report preview: what to look forUFP Technologies will report Q3 earnings after market close on Tuesday. Analysts expect revenue growth of 8.1% year on year, up from 6.5% last year, with an average price target of $355 versus a current price of $283.90.TradingViewUFP Technologies (UFPT) Q3 earnings report preview: what to look forUFP Technologies will report Q3 earnings after market close on Tuesday. Analysts expect revenue growth of 8.1% year on year, up from 6.5% last year. The company has missed revenue estimates multiple times over the past two years.